KAPLAN MATTHEW L. received a stock award from NUVECTIS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/12/2026ACC: 0001104659-26-073455
+35K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
35K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+35K
Price / share
—
Trade value
—
% of position
28.1%
6/11/2026
124.76K→159.76K
Total
Net shares
+35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | A · Award | +35K | — | — | 28.1% | 124.76K | 159.76K |
| Total | +35K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported